Rishi Venkata Puram, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antigens, Human Platelet | 1 | 2020 | 43 | 0.730 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2020 | 641 | 0.590 |
Why?
|
| Purpura, Thrombocytopenic, Idiopathic | 1 | 2020 | 233 | 0.550 |
Why?
|
| CLOCK Proteins | 1 | 2016 | 87 | 0.540 |
Why?
|
| ARNTL Transcription Factors | 1 | 2016 | 98 | 0.530 |
Why?
|
| Autoantibodies | 1 | 2020 | 2035 | 0.400 |
Why?
|
| Neoplastic Stem Cells | 2 | 2016 | 1376 | 0.370 |
Why?
|
| Leukemia, Myeloid, Acute | 4 | 2016 | 3523 | 0.310 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2020 | 3068 | 0.300 |
Why?
|
| Thrombosis | 1 | 2020 | 2968 | 0.280 |
Why?
|
| Pipecolic Acids | 1 | 2020 | 76 | 0.180 |
Why?
|
| Drug Substitution | 1 | 2020 | 281 | 0.150 |
Why?
|
| Platelet Transfusion | 1 | 2020 | 314 | 0.150 |
Why?
|
| Coronary Thrombosis | 1 | 2020 | 495 | 0.140 |
Why?
|
| Arginine | 1 | 2020 | 944 | 0.140 |
Why?
|
| RNA Interference | 2 | 2016 | 2889 | 0.130 |
Why?
|
| Thrombectomy | 1 | 2020 | 680 | 0.130 |
Why?
|
| Shock, Cardiogenic | 1 | 2020 | 688 | 0.120 |
Why?
|
| Casein Kinase Ialpha | 1 | 2014 | 27 | 0.120 |
Why?
|
| Bone Marrow Neoplasms | 1 | 2014 | 104 | 0.110 |
Why?
|
| Gene Knockout Techniques | 1 | 2016 | 809 | 0.110 |
Why?
|
| Integrin beta3 | 1 | 2013 | 122 | 0.110 |
Why?
|
| RNA, Small Interfering | 3 | 2016 | 3505 | 0.100 |
Why?
|
| Warfarin | 1 | 2020 | 1496 | 0.100 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2016 | 713 | 0.100 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2013 | 730 | 0.100 |
Why?
|
| Thrombolytic Therapy | 1 | 2020 | 2161 | 0.090 |
Why?
|
| Sulfonamides | 1 | 2020 | 1938 | 0.090 |
Why?
|
| SOXD Transcription Factors | 1 | 2010 | 47 | 0.090 |
Why?
|
| Drug Therapy, Combination | 1 | 2020 | 6489 | 0.090 |
Why?
|
| gamma-Globins | 1 | 2010 | 95 | 0.090 |
Why?
|
| Erythroid Cells | 1 | 2010 | 238 | 0.080 |
Why?
|
| Stents | 1 | 2020 | 3280 | 0.080 |
Why?
|
| Aspirin | 1 | 2020 | 3282 | 0.080 |
Why?
|
| Combined Modality Therapy | 1 | 2020 | 8642 | 0.080 |
Why?
|
| Gene Silencing | 2 | 2014 | 1538 | 0.080 |
Why?
|
| Repressor Proteins | 2 | 2016 | 3023 | 0.080 |
Why?
|
| Homeodomain Proteins | 1 | 2016 | 2421 | 0.070 |
Why?
|
| Hematopoiesis | 1 | 2016 | 2072 | 0.070 |
Why?
|
| Leukemia | 1 | 2013 | 1511 | 0.060 |
Why?
|
| Circadian Rhythm | 1 | 2016 | 2624 | 0.060 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2014 | 2948 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 2 | 2016 | 21827 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2016 | 8428 | 0.050 |
Why?
|
| MicroRNAs | 1 | 2016 | 3752 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2016 | 18029 | 0.040 |
Why?
|
| Mice | 6 | 2016 | 81183 | 0.040 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2010 | 3617 | 0.040 |
Why?
|
| Oncogene Proteins, Fusion | 2 | 2016 | 1581 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2010 | 5021 | 0.040 |
Why?
|
| Nuclear Proteins | 1 | 2010 | 5853 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 17446 | 0.030 |
Why?
|
| Animals | 6 | 2016 | 168757 | 0.030 |
Why?
|
| Ribosomal Protein S6 | 1 | 2014 | 70 | 0.030 |
Why?
|
| Cell Line, Tumor | 3 | 2016 | 16689 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2016 | 23403 | 0.030 |
Why?
|
| Lovastatin | 1 | 2013 | 120 | 0.030 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2013 | 3386 | 0.020 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2013 | 294 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2013 | 13695 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2016 | 3144 | 0.020 |
Why?
|
| Humans | 7 | 2020 | 744343 | 0.020 |
Why?
|
| GATA1 Transcription Factor | 1 | 2010 | 293 | 0.020 |
Why?
|
| Cell Death | 1 | 2014 | 1706 | 0.020 |
Why?
|
| Small Molecule Libraries | 1 | 2014 | 720 | 0.020 |
Why?
|
| beta Catenin | 1 | 2013 | 1059 | 0.020 |
Why?
|
| Middle Aged | 1 | 2020 | 213383 | 0.020 |
Why?
|
| Erythropoiesis | 1 | 2010 | 705 | 0.020 |
Why?
|
| Cell Movement | 1 | 2016 | 5217 | 0.020 |
Why?
|
| Protein Transport | 1 | 2010 | 1988 | 0.010 |
Why?
|
| Epigenesis, Genetic | 1 | 2016 | 3647 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2014 | 8436 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2016 | 7722 | 0.010 |
Why?
|
| Male | 1 | 2020 | 350118 | 0.010 |
Why?
|
| Base Sequence | 1 | 2013 | 12797 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 9438 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 18111 | 0.010 |
Why?
|
| Histones | 1 | 2010 | 2599 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2016 | 11483 | 0.010 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2013 | 3255 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2013 | 14557 | 0.010 |
Why?
|
| Protein Binding | 1 | 2010 | 9386 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2014 | 5535 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2016 | 12261 | 0.010 |
Why?
|
| Cell Line | 1 | 2010 | 15997 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2014 | 63114 | 0.000 |
Why?
|
| Adult | 1 | 2010 | 214055 | 0.000 |
Why?
|